Statin use is associated with reduced risk of histologic subtypes of esophageal cancer: A nested case-control analysis
Tools
Alexandre, Leo, Clark, Allan B., Bhutta, Hina Y., Holt, Sean, Lewis, Michael P. N. and Hart, Andrew R. (2014) Statin use is associated with reduced risk of histologic subtypes of esophageal cancer: A nested case-control analysis. Gastroenterology, 146 (3). 661–668. ISSN 0016-5085
![]() |
Microsoft Word (acceptance e-mail)
- Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (16kB) |
Abstract
Most patients with esophageal adenocarcinoma (EAC) or squamous cell cancer (ESCC) present with advanced, incurable disease. Statins have reported anti-carcinogenic effects and may be chemoprotective. We investigated the association between regular use of statins and the main histologic subtypes of esophageal malignancy (EAC, esophagogastric junctional adenocarcinoma [EGJA], and ESCC) in the UK general population.
Item Type: | Article |
---|---|
Additional Information: | Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved. |
Uncontrolled Keywords: | esophageal cancer,statins,aetiology,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
Depositing User: | Pure Connector |
Date Deposited: | 20 Jan 2014 15:54 |
Last Modified: | 06 May 2022 00:13 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/46092 |
DOI: | 10.1053/j.gastro.2013.11.046 |
Actions (login required)
![]() |
View Item |